Skip to main content
. 2016 Apr 12;2(4):237–244. doi: 10.1093/ehjqcco/qcw018

Table 2.

Randomized controlled trials including patients with ischaemic heart disease that used mHealth to improve medication adherence

Study Design Population Study intervention Results Limitations
Quilici et al. (2013)20 RCT
1 month
n = 546
Patients with ACS status post-PCI shown to be aspirin-responsive
Daily SMS reminders for aspirin adherence vs. control; 1 month after hospital discharge admitted to Antiplatelet Monitoring Unit to compare adherence and platelet function SMS reminders improved aspirin adherence as reported by patients (OR [95% CI]: 0.37 [0.15–0.90]; P = 0.02) and as shown by platelet testing (OR [95% CI]: 0.43 [0.22–0.86]; P = 0.01)
  • – No long-term follow-up for sustained response

  • – Cost of platelet testing for feasibility in general population

Vollmer et al. (2014)21 RCT
1 year
n = 21 752
Patients with CVD ± type 2 diabetes and suboptimal medication adherence
Arm 1: Interactive voice recognition phone calls (IVR)
Arm 2: IVR-enhanced (IVR+) phone calls, letters, EMR-feedback, mailed materials
Control: Usual care
Both phone interventions significantly increased adherence to statins (IVR+ equal to IVR) and ACEIs/ARBs (IVR+ more than IVR) compared with usual care (1.6–3.7%).
  • – Most participants did not respond to automated voice recognition calls

  • – No long-term follow-up

Wald et al. (2014)22 RCT
6 months
n = 301
Patients prescribed blood pressure and/or lipid lowering meds
Automated daily TM for 2 weeks, alternate days for 2 weeks, then weekly with the goal to assess patients' adherence vs. control (no text) Lower non-adherence rates among TM group 14/150 (9%) vs. control 38/151 (25%) (95% CI: 7–24), P < 0.001. Non-adherence defined as taking <80% of prescribed regimen
  • – Short duration

  • – Baseline educational status and acceptance of technology was not assessed

Park et al. (2014)23 RCT
30 days
n = 90
Patients with ACS status post-PCI at time of discharge
Arm 1: TM for medication and reminders
Arm 2: Educational TM
Control: No TM
Adherence monitored MEMS for statin and antiplatelet
TM patients had higher percentage of correct doses taken (P = 0.02), taken on schedule (P = 0.01), percentage number of doses (P = 0.01)
  • – Self-reported medication adherence

  • – Hawthorne effect of using MEMS

  • – Lacks long-term follow-up

Fang and Li (2015)24 RCT
6 months
n = 280
Patients with CAD confirmed by CT or angiography
Arm 1: SMS
Arm 2: SMS + Micro Lettera
Control: Phone only
Intervention groups had higher cumulative adherence; SMS + Micro Letter (OR [95% CI]: 0.069 [0.032–0.151], P=<0.001), SMS only (OR [95% CI]: 0.339 [0.183–0.629])
  • – Single site data

  • – Cellular data plan required, limits rural participants

Khonsari et al. (2015)25 RCT
8 weeks
n = 62
Patients post-hospital discharge following ACS
Automated SMS-based reminders on medication adherence vs. control (no text) Medication adherence and heart functional status were higher in SMS group (P < 0.001); control group had 4.09 times greater risk of low adherence (95% CI: 1.82–9.18)
  • – Short follow-up

  • – Single centre

  • – Small sample size

  • – Lacks evidence if readmission or death secondary to medication non-adherence

AA-Ag, arachidonic acid-induced platelet aggregation; ACEI/ARB, angiotensin-converting enzyme/angiotensin receptor blocker; ACS, acute coronary syndrome; CAD, coronary artery disease; CI, confidence interval; DBP: diastolic blood pressure; EMR, electronic medical record; IVR, interactive voice response calls; LDL-C: low-density lipoprotein cholesterol; MEMS, Medication Event Monitoring System; NNT, number needed to treat; OR, odds ratio; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; SMS, short messaging service; TM, text messaging.

aMicro Letter platforms provide users in China with access to news and other information via open-access Kik Messenger-like programs.